SSc vs Control | ACA+ vs Control | ATA+ vs Control | ||||
---|---|---|---|---|---|---|
SNP | OR | p | OR | p | OR | p |
rs1044507 | 0.56 (0.40–0.79) | 6.8 × 10−4 | 0.52 (0.29–0.95) | 0.031 | 0.75 (0.29–1.89) | 0.536 |
rs204987 | 2.50 (0.48–12.90) | 0.258 | 2.04 (0.18–22.59) | 0.552 | 0.00 (0.00–NaN) | 0.713 |
rs415929 | 1.02 (0.84–1.25) | 0.824 | 1.28 (0.94–1.74) | 0.120 | 1.92 (1.16–3.17) | 0.0099 |
rs422951 | 0.93 (0.76–1.13) | 0.471 | 1.16 (0.85–1.58) | 0.339 | 1.33 (0.79–2.24) | 0.288 |
rs423023 | 1.03 (0.84–1.27) | 0.774 | 1.27 (0.92–1.75) | 0.139 | 1.75 (1.04–2.94) | 0.033 |
rs443198 | 1.03 (0.88–1.22) | 0.697 | 1.14 (0.87–1.48) | 0.346 | 1.26 (0.79–2.02) | 0.336 |
rs520688 | 1.03 (0.84–1.27) | 0.788 | 1.28 (0.93–1.76) | 0.127 | 1.78 (1.06–3.00) | 0.028 |
rs520692 | 1.17 (0.93–1.47) | 0.191 | 1.51 (1.08–2.12) | 0.016 | 1.76 (1.00–3.11) | 0.047 |
rs520803 | 1.16 (0.92–1.45) | 0.213 | 1.49 (1.06–2.09) | 0.020 | 1.74 (0.99–3.06) | 0.053 |
rs8192579 | 1.07 (0.74–1.56) | 0.719 | 1.20 (0.68–2.14) | 0.525 | 1.67 (0.70–4.03) | 0.245 |
rs915894 | 0.93 (0.78–1.09) | 0.361 | 0.83 (0.64–1.09) | 0.176 | 0.58 (0.35–0.95) | 0.028 |
10CTG | Reference | |||||
13CTG | 0.7 (0.48–1.03) | 0.086 | 0.73 (0.38–1.43) | 0.449 | 0.71 (0.24–2.13) | 0.718 |
12CTG | 0.82 (0.23–2.93) | 1 | 1.79 (0.35–9.1) | 0.822 | 0 (0–∞) | 1 |
11CTG | 1.21 (0.92–1.6) | 0.194 | 1.43 (0.92–2.23) | 0.141 | 0.81 (0.35–1.88) | 0.777 |
9CTG | 1.42 (1.15–1.75) | 0.001 | 1.37 (0.96–1.95) | 0.099 | 1.19 (0.67–2.14) | 0.651 |
6CTG | 1.67 (1.27–2.19) | 3 × 10−4 | 2.05 (1.34–3.11) | 0.001 | 1.21 (0.56–2.59) | 0.773 |
SSc: systemic sclerosis; ACA: anticentromere antibodies; ATA: antibodies to topoisomerase I; SNP: single-nucleotide polymorphism.